| 发明名称 |
NOVEL INSULIN ANALOGS WITH ENHANCED ZINC BINDING. |
| 摘要 |
<p>The invention relates to insulin analogs exhibiting enhanced zinc binding capacity and to stable zinc complexes thereof having a retarded activity in comparison with human insulin. The invention further relates to a method for the production of said insulin analogs and to their use, particularly in pharmaceutical preparations for therapy of type I and type II diabetes mellitus.</p> |
| 申请公布号 |
MXPA00011456(A) |
申请公布日期 |
2002.10.17 |
| 申请号 |
MX2000PA11456 |
申请日期 |
1999.05.21 |
| 申请人 |
AVENTIS PHARMA DEUTSCHLAND GMBH. |
发明人 |
ERTL, JOHANN |
| 分类号 |
C12N15/09;A61K9/08;A61K38/00;A61K38/28;A61P3/10;A61P5/48;C07K14/62;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/17;C12P21/02;(IPC1-7):A61K38/28 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
